相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。α-Mangostin Alleviated Inflammation in Rats With Adjuvant-Induced Arthritis by Disrupting Adipocytes-Mediated Metabolism-Immune Feedback
Ying-Hao Hu et al.
FRONTIERS IN PHARMACOLOGY (2021)
Xanthones from Securidaca inappendiculata antagonized the antirheumatic effects of methotrexate in vivo by promoting its secretion into urine.
Dan-Dan Wang et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2021)
Integrating Network Pharmacology and Metabolomics Study on Anti-rheumatic Mechanisms and Antagonistic Effects Against Methotrexate-Induced Toxicity of Qing-Luo-Yin
Jian Zuo et al.
FRONTIERS IN PHARMACOLOGY (2018)
Metabolic signatures of T-cells and macrophages in rheumatoid arthritis
Cornelia M. Weyand et al.
CURRENT OPINION IN IMMUNOLOGY (2017)
Moving toward personalized medicine in rheumatoid arthritis: SNPs in methotrexate intracellular pathways are associated with methotrexate therapeutic outcome
Aurea Lima et al.
PHARMACOGENOMICS (2016)
Preliminary study for predicting better methotrexate efficacy in Japanese patients with rheumatoid arthritis
Masayuki Hashiguchi et al.
JOURNAL OF PHARMACEUTICAL HEALTH CARE AND SCIENCES (2016)
Interactions between Transporters and Herbal Medicines/Drugs: A Focus on Hepatoprotective Compounds
Aijie Zhang et al.
CURRENT DRUG METABOLISM (2015)
The impact of obesity on the development and progression of rheumatoid arthritis
Axel Finckh et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Molecular Basis for Pharmacokinetics and Pharmacodynamics of Methotrexate in Rheumatoid Arthritis Therapy
Katsuhisa Inoue et al.
DRUG METABOLISM AND PHARMACOKINETICS (2014)
Drug-Drug Interaction Studies of Cardiovascular Drugs Involving P-Glycoprotein, an Efflux Transporter, on the Pharmacokinetics of Edoxaban, an Oral Factor Xa Inhibitor
Jeanne Mendell et al.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2013)
Gain in Quality-adjusted Life-years in Patients with Rheumatoid Arthritis During 1 Year of Biological Therapy: A Prospective Study in Clinical Practice
Louise Linde et al.
JOURNAL OF RHEUMATOLOGY (2013)
Drug interactions with oral antidiabetic agents: pharmacokinetic mechanisms and clinical implications
Aleksi Tornio et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2012)
Pharmacokinetic drug–drug interactions with methotrexate in oncology
Dominique Levêque et al.
Expert Review of Clinical Pharmacology (2011)
High risk of clinical cardiovascular events in rheumatoid arthritis: Levels of associations of myocardial infarction and stroke through a systematic review and meta-analysis
Christophe Meune et al.
ARCHIVES OF CARDIOVASCULAR DISEASES (2010)
Site-specific contribution of proton-coupled folate transporter/haem carrier protein 1 in the intestinal absorption of methotrexate in rats
Tomoharu Yokooji et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2010)
Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research
C. Salliot et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
THE ECONOMIC BURDEN OF BIOLOGICAL THERAPY IN RHEUMATOID ARTHRITIS IN CLINICAL PRACTICE: COST-EFFECTIVENESS ANALYSIS OF SUB-CUTANEOUS ANTI-TNF alpha TREATMENT IN ITALIAN PATIENTS
M. Benucci et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2009)
Intestinal Npt2b Plays a Major Role in Phosphate Absorption and Homeostasis
Yves Sabbagh et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
The use of low dose methotrexate in rheumatoid arthritis - are we entering a new era of therapeutic drug monitoring and pharmacogenomics?
Lisa Stamp et al.
BIOMEDICINE & PHARMACOTHERAPY (2006)
Low-dose methotrexate: A mainstay in the treatment of rheumatoid arthritis
BN Cronstein
PHARMACOLOGICAL REVIEWS (2005)
The H+-dependent reduced folate carrier 1 of humans and the sodium-dependent methotrexate carrier-1 of the rat are orthologs
C Kneuer et al.
FEBS LETTERS (2004)
Reduced folate carrier: biochemistry and molecular biology of the normal and methotrexate-resistant cell
G Bosson
BRITISH JOURNAL OF BIOMEDICAL SCIENCE (2003)
分享论文
